UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000032930
Receipt number R000037538
Scientific Title 13-valent pneumococcal conjugate vaccine (PCV13) administered concurrently with inactivated influenza vaccine for persons over 65 years
Date of disclosure of the study information 2018/06/08
Last modified on 2018/06/08 16:50:11

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

13-valent pneumococcal conjugate vaccine (PCV13) administered concurrently with inactivated influenza vaccine for persons over 65 years

Acronym

Adverse reaction of PCV13 with IIV in elderly

Scientific Title

13-valent pneumococcal conjugate vaccine (PCV13) administered concurrently with inactivated influenza vaccine for persons over 65 years

Scientific Title:Acronym

Adverse reaction of PCV13 with IIV in elderly

Region

Japan


Condition

Condition

Pneumococcal Vaccine

Classification by specialty

Medicine in general Infectious disease

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

Adverse reaction of PCV13

Basic objectives2

Others

Basic objectives -Others

Adverse reaction of PCV13

Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Adverse reaction in 14 days

Key secondary outcomes



Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

65 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

13-valent pneumococcal conjugate vaccine

Key exclusion criteria

N/A

Target sample size

50


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Naoki Kawai

Organization

Kawai Clinic

Division name

Medicine in general

Zip code


Address

4-32 Kanazono-cho Gifu-shi, Gifu, 500- 8113

TEL

058-245-0564

Email

nkawai@city.gifu.med.or.jp


Public contact

Name of contact person

1st name
Middle name
Last name Chigusa Iwasaki

Organization

RICERCA CLINICA Co.,Ltd

Division name

Clinical support center

Zip code


Address

2-18-30 Yaesuhakata Bld.6F, Hakataeki Higashi, Hakata-ku, Fukuoka-shi, Fukuo ka 812-0013

TEL

092-435-1150

Homepage URL


Email

secretary@ricercaclinica.jp


Sponsor or person

Institute

Japan Physicians Association

Institute

Department

Personal name



Funding Source

Organization

N/A

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2018 Year 06 Month 08 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2016 Year 09 Month 12 Day

Date of IRB


Anticipated trial start date

2016 Year 10 Month 01 Day

Last follow-up date

2017 Year 03 Month 31 Day

Date of closure to data entry

2017 Year 08 Month 31 Day

Date trial data considered complete

2017 Year 08 Month 31 Day

Date analysis concluded

2017 Year 10 Month 01 Day


Other

Other related information

Pneumococcal Vaccine


Management information

Registered date

2018 Year 06 Month 08 Day

Last modified on

2018 Year 06 Month 08 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000037538


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name